Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
Nasir Abbas, Jostein Dahle(Oslo University Hospital), Øyvind S. Bruland(University of Oslo), Jørgen Borrebæk(Bayer (Norway)), Helèn Heyerdahl(Nordic Nanovector (Norway)), Jahn Nesland(Oslo University Hospital)
Cited by 57
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
|The Lancet|2025|966
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
|The Lancet Oncology|2014|491
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
|Photochemistry and Photobiology|1995|181